These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 627447)
21. Leprosy reactional states and their treatment. Jolliffe DS Br J Dermatol; 1977 Sep; 97(3):345-52. PubMed ID: 336075 [No Abstract] [Full Text] [Related]
22. [Suspected leprosy]. Velázquez de Castro y Sagarra A; López Bueno R; Gómez Jiménez G Aten Primaria; 1997 Jun; 20(2):107-8. PubMed ID: 9296648 [No Abstract] [Full Text] [Related]
23. Letter: Use of drugs and their effects on leprosy patients. Graver V Int J Lepr Other Mycobact Dis; 1974; 42(1):72. PubMed ID: 4472185 [No Abstract] [Full Text] [Related]
24. Effectiveness of Methotrexate in prednisolone and thalidomide resistant cases of Type 2 lepra reaction: report on three cases. Rahul N; Sanjay KS; Singh S Lepr Rev; 2015 Dec; 86(4):379-82. PubMed ID: 26964434 [No Abstract] [Full Text] [Related]
25. Thalidomide in the treatment of lepra reactions. De las Aguas JT Int J Lepr Other Mycobact Dis; 1971; 39(2):593-7. PubMed ID: 4948095 [No Abstract] [Full Text] [Related]
26. The bases of chemotherapy and immunosuppressive therapy in leprosy. Browne SG Int J Lepr Other Mycobact Dis; 1971; 39(2):406-12. PubMed ID: 4948083 [No Abstract] [Full Text] [Related]
27. The drug treatment of leprosy. Browne SG Practitioner; 1975 Oct; 215(1288):493-500. PubMed ID: 1202470 [No Abstract] [Full Text] [Related]
30. Treatment of Hansen's disease. Trautman JR Cutis; 1976 Jul; 18(1):62-5. PubMed ID: 1017285 [No Abstract] [Full Text] [Related]
31. Effect of zafirlukast on leprosy reactions. Vides EA; Cabrera A; Ahern KP; Levis WR Int J Lepr Other Mycobact Dis; 1999 Mar; 67(1):71-5. PubMed ID: 10407633 [No Abstract] [Full Text] [Related]
32. [Initial clinical results using new, experimentally developed therapeutic forms in leprosy]. Rohde R Z Tropenmed Parasitol; 1973 Dec; 24():Suppl 1:40-52. PubMed ID: 4592436 [No Abstract] [Full Text] [Related]
33. Trials with thalidomide derivatives in leprosy reactions. Sheskin J; Sagher F Lepr Rev; 1968 Oct; 39(4):203-5. PubMed ID: 5722496 [No Abstract] [Full Text] [Related]
34. WHO expert committee on leprosy. World Health Organ Tech Rep Ser; 1970; 459():3-31. PubMed ID: 4993944 [No Abstract] [Full Text] [Related]
35. Lepra reaction. Its relation with fragmentation of Mycobacterium leprae under sulfone therapy. Saul A; Segura N Int J Lepr Other Mycobact Dis; 1966; 34(1):17-22. PubMed ID: 5327411 [No Abstract] [Full Text] [Related]
36. Complement and immunoglobulin determinations in leprosy and lepra reaction. Sagher F; Sheskin J; Zlotnick A; Turk JL Int J Lepr Other Mycobact Dis; 1971; 39(2):541-53. PubMed ID: 5169814 [No Abstract] [Full Text] [Related]
37. [Therapeutic experience on the effect of thalidomidomide on lepra reaction]. Sheskin J Hautarzt; 1975 Jan; 26(1):1-5. PubMed ID: 1090562 [No Abstract] [Full Text] [Related]
39. Thalidomide--effect on T cell subsets as a possible mechanism of action. Moncada B; Baranda ML; González-Amaro R; Urbina R; Loredo CE Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):201-5. PubMed ID: 3874920 [TBL] [Abstract][Full Text] [Related]
40. Lucio's phenomenon and diffuse nonnodular lepromatous leprosy. Rea TH; Levan NE Arch Dermatol; 1978 Jul; 114(7):1023-8. PubMed ID: 686719 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]